Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Osteoprotegerin and the develo...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Osteoprotegerin and the development of myeloma bone disease

Osteoprotegerin and the development of myeloma bone disease

Bibliographic Details
Main Authors: Croucher, P, Shipman, C, Vanderkerken, K
Format: Conference item
Published: 2004
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
    by: Croucher, P, et al.
    Published: (2003)
  • Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
    by: Croucher, P, et al.
    Published: (2001)
  • Bone marrow endothelial cells produce osteoprotegerin: Evidence for a role in the development of myeloma bone disease
    by: De Leenheer, E, et al.
    Published: (2004)
  • Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
    by: Croucher, P, et al.
    Published: (2001)
  • Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
    by: Croucher, P, et al.
    Published: (2000)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs